This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
Kolmen B. K. et al. (1995)
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
Journal of the American Academy of Child and Adolescent Psychiatry
34(2), pp. 223-231
Kolmen B. K. et al. (1997)
Naltrexone in young autistic children: replication study and learning measures.
Journal of the American Academy of Child and Adolescent Psychiatry
36(11), pp. 1570-1578
LeLord G. , Callaway E. , Muh J. (1982)
Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children.
Acta Vitaminologica et Enzymologica
4(1), pp. 27-44
Effects of pyridoxine and magnesium on autistic symptoms-initial observations.
Journal of Autism and Developmental Disorders
11(2), pp. 219-230
Leventhal B. L. et al. (1993)
Clinical and neurochemical effects of fenfluramine in children with autism.
Journal of Neuropsychiatry and Clinical Neurosciences
5(3), pp. 307-315
Journal of Neural Transmission
104(2),
Molecular Autism
February, 5(1), 2.
Marchezan J. et al. (2017)
A placebo-controlled crossover trial of gastrin-releasing peptide in childhood autism.
Clinical Neuropharmacology
May/June, 40(3), pp. 108-112.
Martineau J. et al. (1985)
Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.
Biological Psychiatry
20(5), pp. 467-478
Mudford O. C. et al. (2000)
Auditory integration training for children with autism: no behavioral benefits detected.
American Journal of Mental Retardation
105(2), pp. 118-129
Frontiers in Neuroscience
11
Niederhofer H. , Staffen W. , Mair A. (2002)
Galantamine may be effective in treating autistic disorder.
British Medical Journal
325(7377), pp. 1422
Niederhofer H. , Staffen W. , Mair A. (2003)
Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
Human Psychopharmacology
18(5), pp. 389-393
Autism
14(1), pp. 9-28
Quintana D. S. et al. (2017)
Dose-dependent social-cognitive effects of intranasal oxytocin.
Translational Psychiatry
May, 7(5), e. 1136.